cll whiteboard #3: mechanisms of action of anti-apoptotic bcl2 inhibitors
Published 6 years ago • 14K plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
2:20
cll whiteboard #2: mechanisms of action of anti-cd20 agents
-
6:30
cll whiteboard #1: introduction & mechanisms of action of bcr signaling inhibitors
-
0:30
bcl2
-
1:40
what is a bcl 2 inhibitor and when is it used? #aml
-
3:58
"what is apoptosis?" the apoptotic pathways and the caspase cascade
-
20:43
venetoclax resistance: mechanisms and treatment options
-
3:09
bcl2 inhibition and cll: the role of venetoclax
-
16:04
intrinsic mitochondrial apoptotic pathway. mechanism of apoptosis p53 bcl proteins
-
3:37
clonal evolution and resistance mechanisms to bcl-2 receptor inhibition
-
20:59
targeted inhibition of signal molecules as novel therapy for cll
-
24:22
highlight of cll-related 2016 fda approvals: venetoclax
-
2:12
understanding and overcoming resistance to btk and bcl-2 inhibitors in cll
-
3:05
apoptosis animation
-
1:46
professor david vaux: bcl-2, cell death and cancer research
-
4:13
sequencing therapy in cll: btk and bcl2 inhibitors
-
21:50
update on venetoclax for cll: how low can you go (mrd)?
-
32:12
keynote lecture 2: understanding the relevant immune mechanisms in gi cancer
-
1:53
anti-apoptotic bcl-xl protein
-
28:25
tkis, apoptotic enhancers, and other small molecules in the pipeline